A synthetic version of a protein present in a woman’s body during pregnancy is as effective against breast cancer as the current drug tamoxifen is, according to a study in rodents. The new substance may avoid tamoxifen’s side effects.
Epidemiological research has estimated that, over her lifetime, the average woman has a 1-in-8 chance of developing breast cancer.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.